VividFlo System Validation Study
ConditionGlaucoma
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorVividWhite Pty Ltd
About this trial
This is a 10-participant study to assess the VividFlo System and surgical implantation using a modified technique.
Eligibility criteria
Qualifiers
Be 18 years of age or older.
Be able to understand all study instructions, and willing to comply with all study procedures and the visit schedule.
Provide written, informed consent to participate.
Diagnosed by the investigator, based upon untreated intraocular pressure, disc appearance and visual field abnormalities.
Disqualifiers
Advanced glaucomatous optic neuropathy that threatens fixation, in the opinion of the investigator.
Acute Angle Closure Glaucoma (AACG).
Chronic Angle Closure Glaucoma (CACG) where the eye is phakic.
Congenital glaucoma. Juvenile Open-Angle Glaucoma or Congenital Glaucoma.
Trial design
Treatments tested in this trial
- VividFlo System
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov